Abstract
Tau has shown to be associated with neurodegenerative diseases. In this exploratory study, we investigated the utility of blood-based biomarkers measuring Tau-C, Tau-A, and C1M in Parkinson’s disease (PD) to explore their potential as diagnostic biomarkers in two independent cohorts (TAU-C and TAU-A). We found them to discriminate between healthy donors and PD individuals (all p < 0.001), with Tau-C showing the best diagnostic discrepancy (AUROC = 0.97). Therefore, Tau-C, Tau-A, and C1M may be biomarkers for PD diagnosis.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 1566228 |
Tidsskrift | Frontiers in Neurology |
Vol/bind | 16 |
Antal sider | 5 |
ISSN | 1664-2295 |
DOI | |
Status | Udgivet - 2025 |
Emneord
- Biomarker
- C1M
- Parkinson’s disease
- Tau-A
- Tau-C